Opaleye Management Inc.
CIK 1595855 · last filed 2026-09-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$352.41M
Companies
14
Total Filings
214
Lifetime Open-Market Net
$30.83M
Filer Profile
Reported Address
ONE BOSTON PLACESUITE 2600
BOSTON, MA 02108
Phone
(617) 904-9195
State of Incorporation
MA
Related Filers
HARROW HEALTH, INC. — 57 joint filings, latest 2026-07-31
SANUWAVE Health, Inc. — 14 joint filings, latest 2026-07-31
Cerecor Inc. — 3 joint filings, latest 2020-02-14
Fortress Biotech, Inc. — 3 joint filings, latest 2021-02-12
Recro Pharma, Inc. — 2 joint filings, latest 2015-02-13
BERKSHIRE FUND V L P — same reported address
BERKSHIRE FUND VII-A L P — same reported address
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.
View filings on SEC EDGAR.
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SLGL | 10%+ Owner | 533,779 | $65.94 | $35.20M | $11.02M | 24 | 2026-09-09 |
| GRCE | 10%+ Owner | 2,760,000 | $2.22 | $6.13M | $24.2K | 1 | 2026-08-19 |
| ACOG | 10%+ Owner | 2,998,223 | $8.90 | $26.68M | $6.10M | 19 | 2026-08-04 |
| ETON | 10%+ Owner | 2,665,000 | $57.08 | $152.12M | -$13.95M | 17 | 2026-07-17 |
| SNWV | 10%+ Owner | 5,000 | $4.10 | $20.5K | -$669.0K | 4 | 2026-05-04 |
| HROW | 10%+ Owner | 3,756,000 | $34.48 | $129.51M | -$6.77M | 9 | 2026-03-05 |
| CDXS | 10%+ Owner | 179,989 | $1.47 | $263.7K | $11.11M | 28 | 2025-12-15 |
| HARROW, INC. (HROWM) Delisted | 10%+ Owner | 90,000 | $26.03 | $2.34M | -$571.8K | 16 | 2025-06-11 |
| TARA | 10%+ Owner | 51,500 | $3.82 | $196.7K | $5.07M | 24 | 2024-09-12 |
| Tracon Pharmaceuticals, Inc. (TCON) Delisted | 10%+ Owner | 0 | $0.03 | $0 | $7.74M | 36 | 2023-11-14 |
| TELA | 10%+ Owner | 124,813 | $0.97 | $121.1K | $3.99M | 19 | 2023-04-20 |
| HARROW, INC. (HROWL) Delisted | 10%+ Owner | 3,600,000 | $25.61 | $92.20M | $6.80M | 8 | 2022-12-14 |
| OCUL | 10%+ Owner | 207,500 | $10.49 | $2.18M | $137.9K | 3 | 2020-04-03 |
| HARROW, INC. (IMMY) Delisted | 10%+ Owner | 1,250,000 | — | — | $789.4K | 5 | 2016-03-14 |
Recent Filings · Page 12 of 22
214 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-03-28 | HARROW, INC. (HROWM) Delisted | Buy (P) | +50,000 | $641.0K | EDGAR |
| 2024-03-22 | HARROW, INC. (HROWM) Delisted | Buy (P) | +50,600 | $488.3K | EDGAR |
| 2023-11-16 | HARROW, INC. (HROWM) Delisted | Buy (P) | +25,000 | $200.7K | EDGAR |
| 2023-11-14 | Tracon Pharmaceuticals, Inc. (TCON) Delisted | Sell (S) | −4,764,008 | -$1.40M | EDGAR |
| 2023-09-20 | HARROW, INC. (HROWM) Delisted | Buy (P) | +20,000 | $292.1K | EDGAR |
| 2023-04-20 | TELA | — | — | $0 | EDGAR |
| 2023-03-13 | Tracon Pharmaceuticals, Inc. (TCON) Delisted | Buy (P) | +174,508 | $240.8K | EDGAR |
| 2022-12-30 | TARA | Sell (S) | +15,473 | $41.9K | EDGAR |
| 2022-12-16 | Tracon Pharmaceuticals, Inc. (TCON) Delisted | Buy (P) | +167,500 | $209.9K | EDGAR |
| 2022-12-14 | HARROW, INC. (HROWL) Delisted | Buy (P) | +431,183 | $4.54M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.